Page 428 - Small Animal Clinical Nutrition 5th Edition
P. 428

442        Small Animal Clinical Nutrition




                    Table 25-1. Disorders and drugs that affect taste and smell in people.*
        VetBooks.ir  Disorders                     Cushing’s syndrome         Nasal polyposis
                    Adrenocortical insufficiency
                    Allergic rhinitis              Diabetes mellitus          Niacin deficiency
                    Bronchial asthma               Head trauma                Radiation therapy
                    Burns                          Hepatic cirrhosis          Sinusitis
                    Cancer                         Hypertension               Viral hepatitis (acute)
                    Chronic renal failure          Hypothyroidism             Zinc deficiency
                    Cobalamin deficiency           Influenza-like infections
                    Drugs
                    Drug classification            Examples
                    Amebicides                     Metronidazole
                    Antiepileptic drugs            Phenytoin
                    Anesthetics (local)            Benzocaine, procaine hydrochloride, tetracaine hydrochloride
                    Antihistamines                 Chlorpheniramine maleate
                    Antimicrobial agents           Amphotericin B, ampicillin, cephalosporins, chloramphenicol, gentamicin, griseofulvin,
                                                   kanamycin, lincomycin, neomycin, nitrofurantoin, sulfonamides, streptomycin, tetracyclines
                    Antineoplastic agents          Doxorubicin, methotrexate, vincristine sulfate
                    Antirheumatic, analgesic,      Allopurinol, azathioprine, colchicine, levamisole, D-penicillamine, phenylbutazone
                    antipyretic, antiinflammatory,
                    immunosuppressive agents
                    Antithyroid agents             Propylthiouracil, thiouracil
                    Diuretics and antihypertensive agents  Captopril, furosemide, thiazides
                    Opiates                        Codeine, morphine
                    Sympathomimetic drugs          Amphetamines, ephedrine
                    Others                         Digitalis glycosides, estrogens, iron sorbitex, oral antidiabetic agents, vitamin D
                    *Adapted from Schiffman SS. Taste and smell in disease (first of two parts). New England Journal of Medicine 1983; 308: 1275-1279.
                    Schiffman SS. Taste and smell in disease (second of two parts). New England Journal of Medicine 1983; 308: 1337-1343.



                  tionists have recognized that cachexia and a resultant low body  has been altered to establish a fragile homeostasis. This home-
                  condition score (BCS) are associated with increased risk of  ostasis can be maintained until a new stress supervenes.
                  complications in people (Windsor, 1993). Loss of skeletal and  Affected patients very often do not survive additional stresses
                  visceral proteins can have adverse anatomic and functional con-  such as trauma, surgery, infection or tumors, as might a previ-
                  sequences in food-deprived patients. These adverse effects  ously healthy dog or cat.
                  include anemia, reduced heart muscle mass and function,
                  decreased pulmonary mechanical function and diminished res-  Metabolic Changes Through Days of Food
                  piratory drive, altered intestinal morphology and mildly  Deprivation
                  impaired absorptive abilities (Biden and  Taylor, 1983).  Simple Starvation
                  Cachexia may affect dogs and cats with long-standing cancer,  Simple starvation includes metabolic changes that occur in
                  cardiac disease or renal disease (Chapters 30, 36 and 37, respec-  mammals, in the absence of disease, as days of food deprivation
                  tively). A state of metabolic “accommodation” that prolongs  continue. The time course of metabolic changes and associated
                  survival has been recognized in people with chronic diseases. A  alterations in nutrient usage should guide how these hospital-
                  similar state of metabolic accommodation probably occurs in  ized patients are fed. An understanding of the metabolic
                  chronically ill dogs and cats.                      changes that take place (particularly in the liver) during starva-
                    Accommodation occurs when the energy equilibrium is  tion is essential to understanding metabolic alterations present
                  reestablished at a constant but lower food intake and lean-tis-  during anorexia and disease states.
                  sue wasting is arrested before protein deficiency becomes fatal.  In the postprandial period of well-fed patients, exogenous
                  Accommodation in people is successful when: 1) total lean-tis-  dietary nutrients are used to meet immediate metabolic needs,
                  sue depletion is less than that considered critical, 2) weight is  thus sparing endogenous fuels stored as glycogen, adipose and
                  low but stable and 3) albumin levels and total peripheral WBC  muscle protein. After these needs are met, replenishment of
                  counts are normal with an intact delayed cutaneous hypersen-  glycogen reserves (in the liver, fat and muscle) as well as pro-
                  sitivity response (Hoffer, 1994).                   teins catabolized since the last meal, takes place. Any excess
                    Accommodation with the exception of an intact delayed  energy in the form of carbohydrate, fat or protein is then con-
                  cutaneous hypersensitivity response accurately describes the  verted to triglycerides for storage as fat in adipose, muscle and
                  condition of some chronically ill patients (i.e., those with  liver tissue.In the fed state when serum glucose is high,the liver
                  chronic renal, hepatic or cardiac insufficiency). Some chronical-  becomes a net importer of glucose, trapping it in hepatocytes by
                  ly ill, cachectic cats and dogs may be maintained at a less than  phosphorylation via glucokinase. Glucokinase is an inducible
                  optimal body weight and condition for some time, even though  hepatic enzyme whose maximal enzymatic activity (Km = 180
                  important organ function deficits are apparent. In these cases,  mg/dl) for glucose is reached with the help of insulin, at high
                  metabolic rate has been down regulated and protein turnover  blood glucose concentrations (Engelking and Anwer, 1992).
   423   424   425   426   427   428   429   430   431   432   433